3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF
申请人:ALLERGAN, INC.
公开号:US20190047947A1
公开(公告)日:2019-02-14
Described herein are compounds, or pharmaceutically acceptable salts thereof, of the following formula:
The compounds are useful for treating inflammatory and autoimmune diseases.
本文描述了以下结构的化合物或其药用盐:
这些化合物可用于治疗炎症性和自身免疫性疾病。
DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES
申请人:GALDERMA RESEARCH & DEVELOPMENT
公开号:US20140309208A1
公开(公告)日:2014-10-16
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds are disclosed that are represented by general formula (I). Also disclosed, are pharmaceutical compositions including these compounds and methods of using these compounds and compositions for the treatment of chemokine-mediated pathologies.
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
申请人:Taveras Arthur G.
公开号:US20110213029A1
公开(公告)日:2011-09-01
There are disclosed compounds of the formula
or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof
申请人:ALLERGAN, INC.
公开号:US11208377B2
公开(公告)日:2021-12-28
Described herein are compounds, or pharmaceutically acceptable salts thereof, of the following formula:
The compounds are useful for treating inflammatory and autoimmune diseases.
本文描述的是下式化合物或其药学上可接受的盐类:
这些化合物可用于治疗炎症和自身免疫性疾病。
SAUTER F.; STANETTY P.; KUMMERER W.; BARADAR M., ARCH. PHARM. <APBD-AJ>, 1978, 311, NO 4, 273-279
作者:SAUTER F.、 STANETTY P.、 KUMMERER W.、 BARADAR M.